The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.

Researchers conducted a retrospective study published in June 2025 issue of Rheumatology International to compile evidence on sex-specific differences in systemic lupus erythematosus (SLE), focusing ...

Intravenous belimumab plus SOC vs placebo plus SOC was not linked to an increased risk for infection among patients with SLE.

A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease. Monogenic lupus nephritis is distinct from non-monogenic disease with ...

In the Belimumab in Subjects with Systemic Lupus Erythematosus (BLISS)-BELIEVE Study, combination therapy was not superior to belimumab add-on therapy in non-renal SLE, although a clinical benefit was ...